Isabelle Vigon
Bordeaux, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Dual targeting of CDK6 and LSD1 is synergistic and overcomes differentiation blockade in AML.
Journal: EMBO molecular medicine
Published: October 18, 2024
Dual Inhibition of FLT3 and AXL by Gilteritinib Overcomes Hematopoietic Niche-Driven Resistance Mechanisms in FLT3-ITD Acute Myeloid Leukemia.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 07, 2020
Targeting Tyrosine Kinases in Acute Myeloid Leukemia: Why, Who and How?
Journal: International journal of molecular sciences
Published: June 21, 2019
Hematopoietic niche drives FLT3-ITD acute myeloid leukemia resistance to quizartinib via STAT5-and hypoxia-dependent upregulation of AXL.
Journal: Haematologica
Published: September 12, 2018
PUMILIO/FOXP1 signaling drives expansion of hematopoietic stem/progenitor and leukemia cells.
Journal: Blood
Published: October 24, 2016
Neuraminidase enhances in vitro expansion of human erythroid progenitors.
Journal: European cytokine network
Published: August 02, 2016
CBL controls a tyrosine kinase network involving AXL, SYK and LYN in nilotinib-resistant chronic myeloid leukaemia.
Journal: The Journal of pathology
Published: October 02, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026